The US firm has added a top litigator with experience in pharmaceutical disputes, AI and technology, and complex cross-border litigation, who also made history as the youngest person appointed deputy master of the High Court’s Business and Property Division.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com
29 October 2026 The 95-year-old Wall Street law firm’s management committee has recommended an “orderly wind-down” following a wave of partner exits this year, despite a significant expansion of the IP practice in 2025.
27 October 2026 The departing partners bring expertise across molecular biology, biochemistry, small molecule and peptide drugs, including blockbuster therapies, as well as chemical and mechanical technologies.
26 October 2026 After introducing Microsoft Copilot and specialist legal AI platforms Solve Intelligence and Legora, the firm says the chief technology officer’s priorities will include expanding the use of AI in patent and legal work.